Next Article in Journal
Dexmedetomidine as an Opioid-Sparing Agent in Pediatric Craniofacial Surgery
Previous Article in Journal
Relationships between Dietary Patterns and Indices of Arterial Stiffness and Central Arterial Wave Reflection in 9–11-Year-Old Children
Article

Impact of Point-of-Care Decision Support Tool on Laboratory Screening for Comorbidities in Children with Obesity

1
Department of Family Medicine, Mayo Clinic, Rochester, MN 55905, USA
2
Division of Pediatric Endocrinology and Metabolism, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
3
Department of Health Sciences Research, Mayo Clinic, Rochester, MN 55905, USA
4
Department of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, MN 55905, USA
*
Author to whom correspondence should be addressed.
Drs. Kaufman and Gentile contributed equally to the manuscript.
Received: 23 May 2020 / Revised: 17 June 2020 / Accepted: 24 June 2020 / Published: 27 June 2020
Background: Childhood obesity is associated with dyslipidemia, fatty liver disease, and type 2 diabetes. Expert guidelines recommend screening for these conditions in children with obesity. Aims and objectives: The objective of the study was to compare rates of laboratory screening for dyslipidemia, fatty liver disease, and type 2 diabetes in children with obesity prior to and following implementation of a point-of-care decision support tool. Methods: We performed a retrospective record review of children with body mass index (BMI) ≥95th percentile for age and gender (age 7–18 years) undergoing well-child/sports examination visits. Multivariable logistic regression models were used to adjust for patient and provider confounders. Results: There was no increase in the rates of screening following implementation of the point-of-care decision support tool. Tests were more likely to be recommended in children with severe obesity and in females. Conclusions: The implementation of a point-of-care decision support tool was not associated with improvement in screening rates for dyslipidemia, fatty liver disease, and type 2 diabetes for children with obesity. Further strategies are needed to improve rates of screening for obesity-related comorbid conditions in children with obesity. View Full-Text
Keywords: pediatric obesity; diabetes mellitus; type 2; dyslipidemia; point-of-care systems; liver diseases; comorbidity pediatric obesity; diabetes mellitus; type 2; dyslipidemia; point-of-care systems; liver diseases; comorbidity
Show Figures

Figure 1

MDPI and ACS Style

Kaufman, T.K.; Gentile, N.; Kumar, S.; Halle, M.; Lynch, B.A.; Cristiani, V.; Fischer, K.; Chaudhry, R. Impact of Point-of-Care Decision Support Tool on Laboratory Screening for Comorbidities in Children with Obesity. Children 2020, 7, 67. https://0-doi-org.brum.beds.ac.uk/10.3390/children7070067

AMA Style

Kaufman TK, Gentile N, Kumar S, Halle M, Lynch BA, Cristiani V, Fischer K, Chaudhry R. Impact of Point-of-Care Decision Support Tool on Laboratory Screening for Comorbidities in Children with Obesity. Children. 2020; 7(7):67. https://0-doi-org.brum.beds.ac.uk/10.3390/children7070067

Chicago/Turabian Style

Kaufman, Tara K., Natalie Gentile, Seema Kumar, Marian Halle, Brian A. Lynch, Valeria Cristiani, Karen Fischer, and Rajeev Chaudhry. 2020. "Impact of Point-of-Care Decision Support Tool on Laboratory Screening for Comorbidities in Children with Obesity" Children 7, no. 7: 67. https://0-doi-org.brum.beds.ac.uk/10.3390/children7070067

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop